Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027? | Manifold

Will a CRISPR-based gene editing therapy for transthyretin (ATTR) amyloidosis be available in the US by 2027?

Basic

1

Ṁ10

2027

59%

chance

1D

1W

1M

ALL

This is the first the first in vivo CRISPR-based candidate to begin late-stage clinical development. Phase 3 trials expected in late 2023. https://www.europeanpharmaceuticalreview.com/news/187777/regulatory-first-for-gene-editing-therapy/

This question is managed and resolved by Manifold.

Get

1,000

and

3.00

Sort by:

The current price is approximately the percent of drugs entering Phase III trials that become approved: https://www.science.org/content/blog-post/latest-drug-failure-and-approval-rates

That seems reasonable for now, but I'll definitely watching this closely. Thanks for posting this question, I wouldn't have known about this otherwise!

Related questions

Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?

Will there be an in-vivo gene therapy that edits multiple genes at once approved anywhere in the world before 2030?

Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?

Will there be a CRISPR treatment for Ehlers-Danlos Syndromes before 2040?

The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.

Will gene editing have cured at least one major disease by 2025?

Will 50 Americans have been confirmed to have been cured of thalassemia through gene therapy by the end of 2024?

Will we have gene therapy for a major strain of Crohn's disease by 2030?

Will the FDA approve a disease-modifying treatment for Parkinson's disease by 2025?

By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?

Related questions

Will a gene therapy that edits multiple genes using CRISPR be approved by the FDA before 2030?

Will gene editing have cured at least one major disease by 2025?

Will there be an in-vivo gene therapy that edits multiple genes at once approved anywhere in the world before 2030?

Will 50 Americans have been confirmed to have been cured of thalassemia through gene therapy by the end of 2024?

Which applications of CRISPR technology will achieve regulatory approval for use in humans by 2030?

Will we have gene therapy for a major strain of Crohn's disease by 2030?

Will there be a CRISPR treatment for Ehlers-Danlos Syndromes before 2040?

Will the FDA approve a disease-modifying treatment for Parkinson's disease by 2025?

The FDA will approve an AI developed cure before the end of the decade (<2030) for a previously incurable major illness.

By 2030, will any treatment be shown to increase human lifespan in a randomized controlled trial?

© Manifold Markets, Inc.•Terms + Mana-only Terms•Privacy•Rules